Marc Banjak - Aug 14, 2024 Form 3 Insider Report for iBio, Inc. (IBIO)

Role: Chief Legal Officer
Signature: /s/ Marc Banjak
Stock symbol: IBIO
Transactions as of: Aug 14, 2024
Transactions value $: $0
Form type: 3
Date filed: 8/14/2024, 05:24 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IBIO	Common Stock (RSU)						1.88K	Aug 14, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IBIO	Stock Option (Right to Buy)							Aug 14, 2024	Common Stock	800	$170.40	Direct	F2
holding	IBIO	Stock Option (Right to Buy)							Aug 14, 2024	Common Stock	600	$141.20	Direct	F2
holding	IBIO	Stock Option (Right to Buy)							Aug 14, 2024	Common Stock	3K	$6.92	Direct	F2
holding	IBIO	Stock Option (Right to Buy)							Aug 14, 2024	Common Stock	29K	$1.72	Direct	F2
holding	IBIO	Stock Option (Right to Buy)							Aug 14, 2024	Common Stock	55K	$1.88	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 1,875 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 1,875 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock. The 1,875 RSUs vested pro rata quarterly over 12 months and consists of 468 RSUs which fully vested on June 30, 2023, 469 RSUs which fully vested on September 30, 2023, 469 RSUs which fully vested on December 31, 2023 and 469 RSUs which fully vested on March 31, 2024.
F2	These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by the Company.
F3	These options vest in equal amounts on a quarterly basis over a 3-year period commencing on the date of grant, provided that the reporting person remains employed by the Company.